INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 245 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $304,630 | -16.1% | 9,634 | +8.3% | 0.24% | -12.6% |
| Q2 2023 | $362,901 | -19.0% | 8,899 | -26.0% | 0.28% | +14.0% |
| Q1 2023 | $448,244 | +1.6% | 12,028 | +52.4% | 0.24% | -49.8% |
| Q3 2022 | $441,000 | -2.2% | 7,890 | -9.6% | 0.48% | -4.5% |
| Q2 2022 | $451,000 | -29.4% | 8,728 | -0.8% | 0.51% | -22.8% |
| Q1 2022 | $639,000 | -42.4% | 8,798 | -6.2% | 0.66% | -41.0% |
| Q4 2021 | $1,109,000 | +1.0% | 9,380 | +14.5% | 1.11% | -39.3% |
| Q3 2021 | $1,098,000 | -12.5% | 8,191 | +5.6% | 1.84% | -5.4% |
| Q2 2021 | $1,255,000 | -42.7% | 7,754 | -70.6% | 1.94% | +63.2% |
| Q1 2021 | $2,192,000 | +36.7% | 26,331 | -10.7% | 1.19% | +36.7% |
| Q4 2020 | $1,604,000 | – | 29,500 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |